IndraLab

Statements


USP39 activates SRPK1. 1 / 1
| 1

reach
"In renal cancer cells (RCCs), USP39 promotes malignant progression by regulating the anti-angiogenic variant of vascular endothelial growth factor A (VEGF-A), VEGF-A b, in addition to the RNA splicing-related proteins SRSF1 and SRPK1 [90]."